tryptanthrin

Tryptanthrin is a naturally occurring indoloquinazoline alkaloid primarily isolated from plants such as *Isatis tinctoria* (woad) and *Couroupita guianensis*. It is recognized for its diverse pharmacological profile, including potent anti-inflammatory, antimicrobial, and antineoplastic activities. In the context of autoimmune research, tryptanthrin has been investigated as a potential treatment for rheumatoid arthritis (RA). Its mechanism of action involves the suppression of proinflammatory cytokine production, specifically inhibiting the expression of interleukin-6 (IL-6), interleukin-17A (IL-17A), and granulocyte-macrophage colony-stimulating factor (GM-CSF). Additionally, it reduces the expression and secretion of matrix metalloproteinases (MMP-1 and MMP-3) in fibroblast-like synoviocytes, which are key drivers of joint and bone destruction. Preclinical studies in murine models of collagen-induced arthritis (CIA) have demonstrated that tryptanthrin significantly attenuates clinical symptoms and reduces collagen-specific antibody levels, suggesting its potential as a scaffold for novel RA therapeutics.

Other names

Indolo[2,1-b]quinazoline-6,12-dioneCouropitine